Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activity
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
Seeking Alpha / 6 minutes from now 2 Views
Seeking Alpha / 6 minutes from now 2 Views
Single ascending dose data show IMC-I109V has manageable safety profile and antiviral activity
Comments